The Francis Crick Institute Q&A: Fertility, IVF, and the Science of Reproduction

Podcast overview

The Francis Crick Institute presents a questions‑and‑answers style discussion on fertility, aging, and the science behind reproduction. A panel including Joyce Harper, Ganesh Taylor, Naomi Morris, and Lucy Van der Weele tackles how fertility is changing and what science can offer.

Key insights

• Fertility declines with age for both women and men, with eggs aging more quickly than sperm. IVF success rates drop notably after the mid‑30s for women.
• Egg freezing is common around age 38 in the UK, but experts warn there are no guarantees and emphasize the costs and potential psychological impact.
• Embryo models from stem cells offer a research avenue to study early development beyond ethical limits on human embryos.
• Ethical, societal, and economic considerations surround fertility technologies, including donor conception, identity, and equitable access.

Overview and panel

The host Brian Cox leads a multidisciplinary panel from the Francis Crick Institute to discuss fertility, a topic increasingly central to society as family formation ages shift upward. The conversation weaves together clinical practice, developmental biology, embryology, and social science perspectives to illuminate where fertility science stands today and what the future might hold.

Key sections

• : The panel discusses rising parental ages, the natural decline in female fertility with age, and how male fertility also declines with age, affecting conception and miscarriage risk.
• : IVF is described as the main therapeutic option, with realistic success rates that fall sharply beyond 35. Egg freezing, embryo testing, and genetic screening are explored as adjuncts, with caution about over‑promising outcomes.
• : The biology of ovaries is explained, including a fixed initial egg pool and how many eggs are depleted before puberty. The concept of ovarian reserve and the 'Hunger Games' analogy for selection among many eggs is discussed, along with environmental and lifestyle factors that influence egg quality.
• : Researchers describe using pluripotent stem cells to form embryo‑like models to study early development, aiming to improve implantation, placentation, and prevention of congenital anomalies while navigating ethical constraints.
• : The panel debates preimplantation genetic testing, potential uses of AI in embryo evaluation, and the ethical boundaries of selecting for complex traits versus disease predisposition. Concerns about equity and unintended social consequences are highlighted.
• : IVF often involves addressing male factor infertility, but the discussion emphasizes that fertility is a shared issue, not solely a female one, and donor conception raises identity and telling‑the‑child questions.
• : Ideas such as creating gametes from skin cells or extending embryo culture timelines are discussed, along with the critical role of funding, regulation, and the need for literacy about fertility information to counter marketing myths.

Implications

The conversation underscores that while fertility technologies have transformed reproductive medicine, they come with medical, ethical, and social complexities. The potential for AI to assist or automate parts of the IVF process is weighed against the risk of commercial misalignment and unequal access. The panel ends with a call for thoughtful governance to ensure equitable, safe, and responsible use of emerging reproductive technologies.